Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2012-02-22
Product name
CP-040, CP-050
1.2.1 Relevant identified uses
Stabilization of DNA in collection kit
Emergency telephone
For Emergencies involving dangerous goods call
Icons in SDS
Company Information
company name
DNA Genotek Inc.
e-mail address of the competent person responsible for the Safety Data Sheet
support@dnagenotek.com
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
29 CFR 1910.1200) Physical state : Liquid.
Signal word
WARNING!
Hazard statements
FLAMMABLE LIQUID AND VAPOR. CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION. CONTAINS MATERIAL THAT MAY CAUSE TARGET ORGAN DAMAGE, BASED ON ANIMAL DATA.
Precautionary statements
Keep away from heat, sparks and flame. Do not breathe vapor or mist. Avoid contact with eyes, skin and clothing. Use only with adequate ventilation. Keep container tightly closed and sealed until ready for use. Wash thoroughly after handling. OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200).
Potential Acute Health Effects
Inhalation : Irritating to respiratory system. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion : No known significant effects or critical hazards. Skin May cause skin irritation. Eyes May cause eye irritation.
Potential chronic health
effects : Contains material that may cause target organ damage, based on animal data. Carcinogenicity : No known significant effects or critical hazards. Mutagenicity : No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Target organs : Contains material which may cause damage to the following organs: blood, the reproductive system, liver, upper respiratory tract, skin, eyes, central nervous system (CNS). 1 Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion : No specific data. Skin : Adverse symptoms may include the following: irritation Eyes : Adverse symptoms may include the following: irritation Medical conditions : Pre-existing disorders involving any target organs mentioned in this MSDS as being at aggravated by over- risk may be aggravated by over-exposure to this product. exposure See toxicological information (Section 11)
